Trial Profile
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jan 2024
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Aspirin
- Indications Retinal artery occlusion
- Focus Therapeutic Use
- Acronyms THEIA
- 26 Jan 2024 Status changed from active, no longer recruiting to completed.
- 02 Nov 2023 Planned End Date changed from 1 Oct 2024 to 1 Jan 2024.
- 02 Nov 2023 Planned primary completion date changed from 1 Oct 2024 to 1 Jan 2024.